Commercial Digest, a once a week digest of messages containing informational content from commercial bodies (i.e., publishers, vendors, agents, etc.)

This week’s digest contains 2 messages:

1)     EDP Sciences and BioMedicine

2)     Inaugural Volume of Annual Review of Cancer Biology now available

 

---------------

Message #1:

 

From: Jane Wiejak [mailto:Jane.Wiejak@tbicommunications.com]
Sent: Tuesday, March 14, 2017 3:25 PM
Subject: EDP Sciences and BioMedicine

 

*** APOLOGIES FOR CROSS-POSTING***

I am passing on information on EDP Sciences’ publication of the fully Open Access journal, BioMedicine, in the hope that it will be of interest to the readers of SERIALST. The journal is owned and sponsored by the China Medical University in Taiwan, and thus has no article processing charges. 

Full press release below or at this link: http://bit.ly/edpbiomed

Please contact me or Claus Roll at EDP Sciences (claus.roll@edpsciences.org) for further information.

EDP Sciences now publishing the Open Access Journal BioMedicine

EDP Sciences has announced that it is now publishing the fully Open Access journal, BioMedicine. EDP officially took over publication of the journal at in the beginning of 2017. The first issue published by EDP Sciences is available since beginning of March 2017.

BioMedicine is a peer-reviewed international Open Access journal that publishes high quality scientific research in the fields of translational and personalized medicine, with the goal of disseminating medical science knowledge to improve global health. The journal is owned and sponsored by China Medical University, Taiwan, and as such there are no article processing charges, so it is free for both authors and readers.

Editor-in-Chief, Professor Fuu-Jen Tsai, China Medical University, Taiwan commented: “We are delighted to be working with EDP Sciences as the publisher to take BioMedicine forward. Their strong track record in Open Access publishing allows us to greatly improve the impact and international reach of BioMedicine.”

BioMedicine accepts articles on clinical, laboratory and social research in translational and personalized medicine, especially in the field of rare diseases. The following article types accepted: reviews, original articles, case reports, short communications, and letters to the Editor.

“The advances in medical science knowledge provide hope for improved global health”, commented Agnès Henri, Editorial Director at EDP Sciences, “We look forward to working with BioMedicine to expand the reach and increase the impact of the journal”. 

The latest articles will be available to read online at http://biomedicine.edp-open.org/

 

---------------

Message #2:

 

From: David Armstrong [mailto:davidarmstrong@tbicommunications.com]
Sent: Wednesday, March 15, 2017 6:06 AM
Subject: Inaugural Volume of Annual Review of Cancer Biology now available

 

*** Apologies for cross-posting ***

 

Dear colleagues,

 

I thought the list might be interested to know that Annual Reviews has just launched its 47th journal, the Annual Review of Cancer Biology. The first volume of the Annual Review of Cancer Biology contains more than twenty reviews that address the basic mechanisms of cancer development and the translation to therapeutic strategies today and in the future.

 

More information can be found in the press release available at: https://urldefense.proofpoint.com/v2/url?u=http-3A__bit.ly_AnnRevCancerBio&d=DwIFAg&c=GTxgfYI6i4KYikqC6GK_Jzn2mYGEh-v4HEPYCyQcJzU&r=R46WLYcoR1itw9wbyfsvoZC7zK376Ouj7YOhhnz7MBg&m=wB_qf5wxJfumBpDmmDpz7SXlO_hUYCjFLbg_xxTt5zE&s=mJl3rp4v1SSYEgffE13dS3k7cqFcLxpWGJuqHk9wcRo&e=

 

The first volume of the Annual Review of Cancer Biology is available online: https://urldefense.proofpoint.com/v2/url?u=http-3A__www.annualreviews.org_journal_cancerbio&d=DwIFAg&c=GTxgfYI6i4KYikqC6GK_Jzn2mYGEh-v4HEPYCyQcJzU&r=R46WLYcoR1itw9wbyfsvoZC7zK376Ouj7YOhhnz7MBg&m=wB_qf5wxJfumBpDmmDpz7SXlO_hUYCjFLbg_xxTt5zE&s=gPeUYDUA0gLvxbRLl4lquiWbFmQl_8cbboNtqAo8vZw&e=

 

 

Best wishes,

David Armstrong

 

 

Senior Marketing Manager, TBI Communications

Tel: +44 (0)1865 875896

Email: david.armstrong@tbicommunications.com

 

Web: www.tbicommunications.com

Twitter: @tbicomms

Linkedin: uk.linkedin.com/in/daarmstrong _____________________________________________

 

TBI Communications Limited is a limited company registered in England and Wales.

Registered number: 5375015.

Registered office: 62 Church Road, Wheatley, Oxford. Oxfordshire. OX33 1LZ, UK ############################